Literature DB >> 26201309

Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.

V C Gourzi1, E K Kapsogeorgou1, N C Kyriakidis1, A G Tzioufas1.   

Abstract

The elevated tissue expression of Ro/SSA and La/SSB autoantigens appears to be crucial for the generation and perpetuation of autoimmune humoral responses against these autoantigens in Sjögren's syndrome (SS). The mechanisms that govern their expression are not known. miRNAs, the post-transcriptional regulators of gene expression, might be implicated. We have identified previously the miRNAs let7b, miR16, miR181a, miR200b-3p, miR200b-5p, miR223 and miR483-5p that are predicted to target Ro/SSA [Ro52/tripartite motif-containing protein 21 (TRIM21), Ro60/TROVE domain family, member 2 (TROVE2)] and La/SSB mRNAs. To study possible associations with autoantigen mRNA expression and disease features, their expression was investigated in minor salivary gland (MSG) tissues, peripheral blood mononuclear cells (PBMC) and long-term cultured non-neoplastic salivary gland epithelial cells (SGEC) from 29 SS patients (20 of 29 positive for autoantibodies to Ro/SSA and La/SSB) and 24 sicca-complaining controls. The levels of miR16 were up-regulated in MSGs, miR200b-3p in SGECs and miR223 and miR483-5p in PBMCs of SS patients compared to sicca-complaining controls. The MSG levels of let7b, miR16, miR181a, miR223 and miR483-5p were correlated positively with Ro52/TRIM21-mRNA. miR181a and miR200b-3p were correlated negatively with Ro52/TRIM21 and Ro60/TROVE2 mRNAs in SGECs, respectively, whereas let7b, miR200b-5p and miR223 associated with La/SSB-mRNA. In PBMCs, let7b, miR16, miR181a and miR483-5p were correlated with Ro52/TRIM21, whereas let7b, miR16 and miR181a were also associated with La/SSB-mRNA expression. Significantly lower miR200b-5p levels were expressed in SS patients with mucosa-associated lymphoid tissue (MALT) lymphoma compared to those without. Our findings indicate that miR16, miR200b-3p, miR223 and miR483-5p are deregulated in SS, but the exact role of this deregulation in disease pathogenesis and autoantigen expression needs to be elucidated.
© 2015 British Society for Immunology.

Entities:  

Keywords:  La/SSB; Ro52/TRIM21; Ro60/TROVE2; Sjögren's syndrome; autoantigens; miRNAs

Mesh:

Substances:

Year:  2015        PMID: 26201309      PMCID: PMC4578504          DOI: 10.1111/cei.12664

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.

Authors:  Erika Zilahi; Tünde Tarr; Gábor Papp; Zoltán Griger; Sándor Sipka; Margit Zeher
Journal:  Immunol Lett       Date:  2011-10-20       Impact factor: 3.685

2.  Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients.

Authors:  Fumiko Katsushima; Atsushi Takahashi; Natsumi Sakamoto; Yukiko Kanno; Kazumichi Abe; Hiromasa Ohira
Journal:  Hepatol Res       Date:  2013-08-15       Impact factor: 4.288

3.  Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells.

Authors:  Ioannis D Dimitriou; Efstathia K Kapsogeorgou; Rasmi F Abu-Helu; Haralampos M Moutsopoulos; Menelaos N Manoussakis
Journal:  Eur J Oral Sci       Date:  2002-02       Impact factor: 2.612

4.  Pathogenesis of Sjögren's syndrome: what we know and what we should learn.

Authors:  Athanasios G Tzioufas; Efstathia K Kapsogeorgou; Haralampos M Moutsopoulos
Journal:  J Autoimmun       Date:  2012-02-10       Impact factor: 7.094

5.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

6.  MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.

Authors:  Gerardo Ferrer; Alfons Navarro; Kate Hodgson; Marta Aymerich; Arturo Pereira; Tycho Baumann; Mariano Monzo; Carol Moreno; Emili Montserrat
Journal:  Leuk Lymphoma       Date:  2013-01-29

7.  Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome.

Authors:  P Tengnér; A K Halse; H J Haga; R Jonsson; M Wahren-Herlenius
Journal:  Arthritis Rheum       Date:  1998-12

8.  Circulating microRNA expression profiles associated with systemic lupus erythematosus.

Authors:  Anting Liu Carlsen; Aaron J Schetter; Christoffer T Nielsen; Christian Lood; Steen Knudsen; Anne Voss; Curtis C Harris; Thomas Hellmark; Mårten Segelmark; Søren Jacobsen; Anders A Bengtsson; Niels H H Heegaard
Journal:  Arthritis Rheum       Date:  2013-05

9.  Down-regulation of miR-223 contributes to the formation of Gottron's papules in dermatomyositis via the induction of PKCɛ.

Authors:  Kuniko Inoue; Masatoshi Jinnin; Keitaro Yamane; Takamitsu Makino; Ikko Kajihara; Katsunari Makino; Norithosi Honda; Wakana Nakayama; Satoshi Fukushima; Hironobu Ihn
Journal:  Eur J Dermatol       Date:  2013-04-01       Impact factor: 3.328

Review 10.  Review of miR-200b and cancer chemosensitivity.

Authors:  Bing Feng; Rui Wang; Long-Bang Chen
Journal:  Biomed Pharmacother       Date:  2012-06-29       Impact factor: 6.529

View more
  24 in total

1.  Autoantigen-targeting microRNAs in Sjögren's syndrome.

Authors:  Ying Yang; Linyi Peng; Weizhi Ma; Fan Yi; Zhenxi Zhang; Hua Chen; Yongqing Guo; Li Wang; Li Dan Zhao; Wenjie Zheng; Jinghui Li; Fengchun Zhang; Quan Du
Journal:  Clin Rheumatol       Date:  2016-02-18       Impact factor: 2.980

Review 2.  Review of autoantigens in Sjögren's syndrome: an update.

Authors:  Louis Tong; Vanessa Koh; Bernard Yu-Hor Thong
Journal:  J Inflamm Res       Date:  2017-08-07

Review 3.  A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.

Authors:  Adrian Y S Lee
Journal:  Rheumatol Int       Date:  2017-04-17       Impact factor: 2.631

Review 4.  Innate immunity in Sjögren's syndrome.

Authors:  Jeremy Kiripolsky; Liam G McCabe; Jill M Kramer
Journal:  Clin Immunol       Date:  2017-04-08       Impact factor: 3.969

5.  Decreased microRNA-181a and -16 expression levels in the labial salivary glands of Sjögren syndrome patients.

Authors:  Yuhua Wang; Guohua Zhang; Lingling Zhang; Miansong Zhao; Hongdong Huang
Journal:  Exp Ther Med       Date:  2017-10-31       Impact factor: 2.447

6.  Genetics and epigenetics in primary Sjögren's syndrome.

Authors:  Juliana Imgenberg-Kreuz; Astrid Rasmussen; Kathy Sivils; Gunnel Nordmark
Journal:  Rheumatology (Oxford)       Date:  2021-05-14       Impact factor: 7.580

Review 7.  The potential relationship between Flammer and Sjögren syndromes: the chime of dysfunction.

Authors:  Babak Baban; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-08-14       Impact factor: 6.543

8.  Effect of mesenchymal stem cells on Sjögren-like mice and the microRNA expression profiles of splenic CD4+ T cells.

Authors:  Guang-Feng Ruan; Ling Zheng; Jia-Shu Huang; Wan-Xue Huang; Bang-Dong Gong; Xing-Xing Fang; Xiao-Yu Zhang; Jian-Ping Tang
Journal:  Exp Ther Med       Date:  2017-04-06       Impact factor: 2.447

9.  Plant-Derived Chimeric Virus Particles for the Diagnosis of Primary Sjögren Syndrome.

Authors:  Elisa Tinazzi; Matilde Merlin; Caterina Bason; Ruggero Beri; Roberta Zampieri; Chiara Lico; Elena Bartoloni; Antonio Puccetti; Claudio Lunardi; Mario Pezzotti; Linda Avesani
Journal:  Front Plant Sci       Date:  2015-12-01       Impact factor: 5.753

10.  Sjögren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFβ signaling.

Authors:  Adrienne E G Williams; Kevin Choi; Annie L Chan; Yun Jong Lee; Westley H Reeves; Michael R Bubb; Carol M Stewart; Seunghee Cha
Journal:  Arthritis Res Ther       Date:  2016-05-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.